Bell Ceremonies

Adicet Rings the Nasdaq Stock Market Closing Bell

Published

Adicet (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing first-in-class allogeneic gamma delta chimeric antigen receptor T cell therapies for cancer, visits the Nasdaq MarketSite in Times Square. In honor of the occasion, Chen Schor, President and CEO, rings the Closing Bell.

Nasdaq Watch

See what's playing at Nasdaq

Watch Now